Clinical Trial Update: Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the fixed-dose combination grazoprevir/elbasvir for hepatitis C virus genotype 4 in kidney transplant recipients is ongoing,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Zepatier (elbasvir/grazoprevir)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Hepatitis C | Phase 4 | Status: UNKNOWN